Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tri-Immune Boost is a compounded triple-defense immunity formula administered via intramuscular (IM) injection. It consists of a synergistic blend of three active ingredients: glutathione (200 mg/mL), ascorbic acid (200 mg/mL), and zinc sulfate (2.5 mg/mL). Glutathione acts as a potent antioxidant that protects host immune cells and supports lymphocyte function; ascorbic acid (Vitamin C) supports both innate and adaptive immune responses; and zinc sulfate contributes to the development and function of immune processes and wound healing. The formula is not a novel pharmaceutical drug developed by a single company but is a compounded preparation offered by multiple wellness clinics and compounding pharmacies across the United States. It is primarily used to boost weakened immune systems, help suppress common infections such as colds and flu, reduce inflammation, decrease oxidative stress, and promote wound healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tri-Immune Boost.